换一批
换一批HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes.
第一作者：
Sophia S,Wang
第一单位：
Department of Population Sciences, Beckman Research Institute and the City of Hope, Duarte, California. sowang@coh.org.
作者：
Sophia S,Wang [1]
;
Mary,Carrington [2]
;
Sonja I,Berndt [3]
;
Susan L,Slager [4]
;
Paige M,Bracci [5]
;
Jenna,Voutsinas [6]
;
James R,Cerhan [4]
;
Karin E,Smedby [7]
;
Henrik,Hjalgrim [8]
;
Joseph,Vijai [9]
;
Lindsay M,Morton [10]
;
Roel,Vermeulen [11]
;
Ora,Paltiel [3]
;
Claire M,Vajdic [12]
;
Martha S,Linet [13]
;
Alexandra,Nieters [14]
;
Silvia,de Sanjose [15]
;
Wendy,Cozen [3]
;
Elizabeth E,Brown [16]
;
Jennifer,Turner [17]
;
John J,Spinelli [18]
;
Tongzhang,Zheng [19]
;
Brenda M,Birmann [20]
;
Christopher R,Flowers [21]
;
Nikolaus,Becker [22]
;
Elizabeth A,Holly [23]
;
Eleanor,Kane [24]
;
Dennis,Weisenburger [25]
;
Marc,Maynadie [26]
;
Pierluigi,Cocco [27]
;
Demetrius,Albanes [28]
;
Stephanie J,Weinstein [5]
;
Lauren R,Teras [29]
;
W Ryan,Diver [30]
;
Stephanie J,Lax [31]
;
Ruth C,Travis [32]
;
Rudolph,Kaaks [3]
;
Elio,Riboli [3]
;
Yolanda,Benavente [33]
;
Paul,Brennan [33]
;
James,McKay [29]
;
Marie-Hélène,Delfau-Larue [34]
;
Brian K,Link [28]
;
Corrado,Magnani [35]
;
Maria Grazia,Ennas [17]
;
Giancarlo,Latte [18]
;
Andrew L,Feldman [36]
;
Nicole Wong,Doo [37]
;
Graham G,Giles [37]
;
Melissa C,Southey [38]
;
Roger L,Milne [39]
;
Kenneth,Offit [40]
;
Jacob,Musinsky [41]
;
Alan A,Arslan [42]
;
Mark P,Purdue [43]
;
Hans-Olov,Adami [44]
;
Mads,Melbye [44]
;
Bengt,Glimelius [45]
;
Lucia,Conde [46]
;
Nicola J,Camp [44]
;
Martha,Glenn [45]
;
Karen,Curtin [10]
;
Jacqueline,Clavel [10]
;
Alain,Monnereau [47]
;
David G,Cox [48]
;
Hervé,Ghesquières [49]
;
Gilles,Salles [3]
;
Paulo,Bofetta [50]
;
Lenka,Foretova [9]
;
Anthony,Staines [51]
;
Scott,Davis [52]
;
Richard K,Severson [53]
;
Qing,Lan [54]
;
Angela,Brooks-Wilson [54]
;
Martyn T,Smith [54]
;
Eve,Roman [55]
;
Anne,Kricker [56]
;
Yawei,Zhang [56]
;
Peter,Kraft [56]
;
Stephen J,Chanock [57]
;
Nathaniel,Rothman [58]
;
Patricia,Hartge [56]
;
Christine F,Skibola [59]
作者单位：
Department of Population Sciences, Beckman Research Institute and the City of Hope, Duarte, California. sowang@coh.org.
[1]
Cancer and Inflammation Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, and Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts.
[2]
Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland.
[3]
Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
[4]
Department of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, California.
[5]
Department of Population Sciences, Beckman Research Institute and the City of Hope, Duarte, California.
[6]
Department of Medicine Solna, unit of clinical epidemiology, Karolinska Institutet, Stockholm, Sweden.
[7]
Hematology Center, Karolinska University Hospital, Stockholm, Sweden.
[8]
Department of Epidemiology Research, Division of Health Surveillance and Research, Statens Serum Institut, Copenhagen, Denmark.
[9]
Department of Hematology, Rishospitalet, Copenhagen, Denmark.
[10]
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York.
[11]
Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.
[12]
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.
[13]
Braun School of Public Health and Community Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
[14]
Centre for Big Data Research in Health, The University of New South Wales, Sydney, New South Wales, Australia.
[15]
Centre for Chronic Immunodeficiency, University Medical Center Freiburg, Freiburg, Baden-Württemberg, Germany.
[16]
Unit of Infections and Cancer, Cancer Epidemiology Research Programme, Institut Català d' Oncologia, IDIBELL, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.
[17]
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
[18]
Norris Comprehensive Cancer Center, Keck School of Medicine of USC, Departments of Preventive Medicine and Pathology, University of Southern California, Los Angeles, Calfornia.
[19]
Department of Pathology, School of Medicine and the UAB Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, Alabama.
[20]
Department of Histopathology, Douglass Hanly Moir Pathology, Sydney, Australia.
[21]
Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia.
[22]
Cancer Control Research, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
[23]
School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
[24]
Department of Epidemiology, School of Public Health, Brown University, Providence, Rhode Island.
[25]
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
[26]
Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.
[27]
Division of Clinical Epidemiology, German Cancer Research Centre, Heidelberg, Baden-Württemberg, Germany.
[28]
Department of Health Sciences, University of York, York, United Kingdom.
[29]
Department of Pathology, City of Hope, Duarte, California.
[30]
Registry of Hematological Malignancies of Cote d'Or, INSERM UMR1231, University of Burgundy and Dijon University Hospital, Dijon, France.
[31]
Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Cagliari, Italy.
[32]
Epidemiology Research Program, American Cancer Society, Atlanta, Georgia.
[33]
Cancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom.
[34]
School of Public Health, Imperial College London, London, United Kingdom.
[35]
International Agency for Research on Cancer, Lyon, France.
[36]
Department of Immunology, CHU Henri Mondor, Créteil, France.
[37]
INSERM U 955, CHU Henri Mondor, Créteil, France.
[38]
Department of Internal Medicine, Carver College of Medicine, The University of Iowa, Iowa City, Iowa.
[39]
Center of Oncological Prevention (CPO) Piemonte and Unit of Medical Statistics and Epidemiology, Department Translational Medicine, University of Piemonte Orientale, Novara, Italy.
[40]
Department of Biomedical Science, University of Cagliari, Monserrato, Cagliari, Italy.
[41]
Division of Hematology, S. Francesco Hospital, Nuoro, Italy.
[42]
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
[43]
Cancer Epidemiology & Intelligence Division, Cancer Council Victoria, Melbourne, Australia.
[44]
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
[45]
Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Melbourne, Victoria, Australia.
[46]
Department of Obstetrics and Gynecology, New York University School of Medicine, New York City, New York.
[47]
Department of Environmental Medicine, New York University School of Medicine, New York City, New York.
[48]
Perlmutter Cancer Center, NYU Langone Medical Center, New York City, New York.
[49]
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
[50]
Department of Medicine, Stanford University School of Medicine, Stanford, Calfornia.
[51]
Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
[52]
Bill Lyons Informatics Centre, UCL Cancer Institute, University College London, London, United Kingdom.
[53]
Department of Internal Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah.
[54]
Epidemiology of Childhood and Adolescent Cancers Group, Inserm, Center of Research in Epidemiology and Statistics Sorbonne Paris Cité (CRESS), Paris, France.
[55]
Université Paris Descartes, Paris, France.
[56]
Registre des hémopathies malignes de la Gironde, Institut Bergonié, University of Bordeaux, Inserm, Team EPICENE, UMR 1219, France.
[57]
Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom; Cancer Research Center of Lyon, INSERM UMR1052, Center Léon Bérard, Lyon, France.
[58]
Laboratoire de Biologie Moléculaire de la Cellule UMR 5239, Centre National de la Recherche Scientifique, Pierre benite Cedex, France.
[59]
Department of Hematology, Hospices Civils De Lyon, Centre Hospitalier Lyon-Sud and Université Claude Bernard, Lyon, France.
[60]
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
[61]
Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, MF MU, Brno, Czech Republic.
[62]
School of Nursing and Human Sciences, Dublin City University, Dublin, Ireland.
[63]
Fred Hutchinson Cancer Research Center and School of Public Health and Community Medicine, University of Washington, Seattle, Washington.
[64]
Department of Family Medicine and Public Health Sciences, Wayne State University, Detroit, Michigan.
[65]
Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, British Columbia, Canada.
[66]
Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada.
[67]
Division of Environmental Health Sciences, School of Public Health, University of California, Berkeley, Berkeley, California.
[68]
Sydney School of Public Health, The University of Sydney, Sydney, Australia.
[69]
Department of Surgery, Yale School of Medicine, New Haven, Connecticut.
[70]
Department of Environmental Health Sciences, Yale School of Public Health, New Haven.
[71]
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
[72]
Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
[73]
主题词
病例对照研究(Case-Control Studies);女(雌)性(Female);遗传异质性(Genetic Heterogeneity);全基因组关联研究(Genome-Wide Association Study);杂合子(Heterozygote);组织相容性抗原Ⅰ类(Histocompatibility Antigens Class I);组织相容性抗原Ⅱ类(Histocompatibility Antigens Class II);人类(Humans);淋巴瘤, 非霍奇金(Lymphoma, Non-Hodgkin);男(雄)性(Male);前瞻性研究(Prospective Studies)
DOI
10.1158/0008-5472.CAN-17-2900
PMID
29735552
发布时间
2024-06-15
- 浏览40
Cancer research
Cancer research
4086-4096页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
